Submitted by Sabin Admin on
Houston Chronicle
Austin, Houston and San Antonio, three of the most populated cities in Texas, have something in common with the world's great population centers - Cairo, Jerusalem, Petra, Baghdad, Shiraz, Delhi, Kath
Read more
Submitted by Sabin Admin on
Washington, DC – July 19, 2011 – Neglected tropical diseases (NTDs), which primarily affect poor people in developing countries, are now being found among the poor in relatively affluent regions as well, particularly in parts of Eastern Europe with a history of war and conflict. This is the focus of a new article in the International Journal of Infectious Diseases authored by Dr. Peter Hotez, President of the Sabin Vaccine Institute, and Meredith Gurwith of Georgetown University.
Submitted by Sabin Admin on
The Academy of Medicine, Engineering and Science of Texas (TAMEST) welcomed Sabin President Dr. Peter Hotez as one of its six newest members today.
TAMEST, founded in 2004, brings together Texas’ top scientific, academic and corporate minds to further position the state as a national research leader and to provide broader recognition of the state's top achievers in medicine, engineering and science. Members include Texas Nobel Laureates and more than 240 National Academies members.
Submitted by Sabin Admin on
Through joint programs between the US Department of State and its United States Agency for International Development (USAID) and the additional hiring of more than 1,000 Foreign and Civil Service Officers in each organization, and reflecting the results of a new Quadrennial Diplomacy and Development Review, in the coming years the State Department and USAID would now work more closely to enhance global development in the context of diplomacy.
Submitted by Sabin Admin on
Washington, DC – June 2, 2011 – A new perspective authored by Peter Hotez, Jeffrey Sachs and others in the New England Journal of Medicine reinforces the importance of integrating neglected tropical disease (NTD) control measures into existing control efforts for HIV/AIDS, tuberculosis and malaria.
